| Schedule of net debt |
| | | | | | | | | | | | | Cash and | | Other | | | | | | | cash | | financial | | | | | Leases | | equivalents | | assets | | Total | Net asset / (debt) as at December 31, 2023 | | (344,336) | | 3,865,481 | | 848 | | 3,521,993 | Cash flows | | 73,688 | | (623,425) | | 5,648 | | (544,089) | Effect of modification to lease terms | | (23,940) | | — | | — | | (23,940) | Disposal | | 10,178 | | — | | — | | 10,178 | Assets transferred to Neurosterix Pharma Sàrl | | 242,416 | | — | | — | | 242,416 | Foreign exchange differences | | — | | 99,682 | | — | | 99,682 | Net asset / (debt) as at December 31, 2024 | | (41,994) | | 3,341,738 | | 6,496 | | 3,306,240 | Cash flows | | 7,306 | | (1,667,940) | | (1,366) | | (1,662,000) | Foreign exchange differences | | — | | (35,186) | | — | | (35,186) | Net asset / (debt) as at December 31, 2025 | | (34,688) | | 1,638,612 | | 5,130 | | 1,609,054 |
|
| Schedule of lease liabilities |
| | | | | | | | | | | | | | | | | More | | Total | | Carrying | | | Less than | | 1 to 5 | | than | | cash out | | amount | At December 31, 2024 | | 1 Year | | Years | | 5 Years | | flows | | liabilities | Lease liabilities | | 9,240 | | 38,499 | | — | | 47,739 | | 41,994 | | | | | | | | | | | | | | | | | | More | | Total | | Carrying | | | Less than | | 1 to 5 | | than | | cash out | | amount | At December 31, 2025 | | 1 Year | | Years | | 5 Years | | flows | | liabilities | Lease liabilities | | 9,240 | | 29.259 | | — | | 38,499 | | 34,688 |
|